<DOC>
	<DOC>NCT00449501</DOC>
	<brief_summary>The purpose of this study is to demonstrate whether subjects respond similarly to the Onset of Effect Questionnaire (OEQ) administered pre-dose versus post-dose, while receiving SYMBICORT® pMDI 80/4.5 μg x 2 actuations twice daily or budesonide HFA pMDI 80 μg x 2 actuations twice daily.</brief_summary>
	<brief_title>A Two-week Study Assessing the Onset of Effect Questionnaire Administered Pre-dose Versus Post-dose in Adult Subjects</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Budesonide, Formoterol Fumarate Drug Combination</mesh_term>
	<mesh_term>Formoterol Fumarate</mesh_term>
	<mesh_term>Budesonide</mesh_term>
	<criteria>Male or Female, &gt; 18 years of age Mild to moderate asthma requiring treatment with an inhaled corticosteroid Diagnosis of asthma for at least 6 months Subjects requiring treatment with systemic corticosteroids (e.g., oral, parenteral, ocular) Subjects with severe asthma, as judged by investigator Any significant disease or disorder that may jeopardize a subject's safety</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>Mild Asthma</keyword>
	<keyword>Moderate Asthma</keyword>
</DOC>